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a b s t r a c t
Design and synthesis of organoselenium compounds with high thiol peroxidase (TPx) and low thiol oxi-
dase (TOx) activities have been a difﬁcult task and remains a synthetic-activity relationship dilemma. In
this regard we are reporting for the ﬁrst time a detail experimental data (both in vitro and in vivo) about
the anti-oxidant and toxicological proﬁle of an Imine (–N ) containing organoseleniumcompound (Com-
pound A). The TPx activity of Compound Awas signiﬁcantly higher than diphenyl diselenide (DPDS). Both
Compound A and DPDS protected sodium nitropruside (SNP) induced thiobarbituric acid reactive species
(TBARS) production in rats tissue homogenate with signiﬁcantly higher activity observed for Compound
A than DPDS (p<0.05). The Compound A also exhibited strong antioxidant activity in the DPPH and ABTS
radical scavenging assays. This study reveals that an imine group close to selenium atom drastically
enhances the catalytic activities in the aromatic thiol (PhSH) assay systems. The oxidation of biologically
signiﬁcant thiols reﬂects the toxicity of the compounds. However, the present data showed that treat-
ment with Compound A at 0, 10, 25 or 50mg/kg was not associated with mortality or body weight loss.
Similarly it did not inhibit-ALA-D andNa+1/K+1 ATPase (sulfhydryl group containing enzymes) activities
after acute oral treatment; rather it enhanced non-protein thiols (NPSH) concentration. The Compound
A did not cause any oxidative stress as measured by TBARS production in rat’s tissue preparation. Our
data also indicate that exposure to Compound A did not affect plasma transaminase activities or levels
of urea and creatinine in rats. Ascorbic acid is always considered a marker of oxidative stress and the
reduction of its content may indicate an increase in oxidative stress. Treatment with Compound A did
not alter Ascorbic acid levels in rats. The conducted in vitro and in vivo tests show the versatile therapeutic
potential of this compound in the area of free radical induced damages, will undoubtedly enhance our
understanding of the mechanism of model compounds and may ultimately yield insights that result in
improved GPx mimics.
. Introduction
Various organoselenium compounds having a direct
elenium–nitrogen (Se–N) bond have been shown to mimic the
ctive site of glutathione peroxidase (GPx). Among them the most
romising drug is Ebselen (1,2-phenyl- 1,2-benzoisoselenazol-
-(2H)-one), a heterocyclic compound exhibiting interesting
linical properties in the area of free radical induced damages
nd therapies [1]. Since the discovery that Ebselen mimics the
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hydroperoxides reducing ability of GPx, several groups have
worked towards the synthesis of better GPx mimics. All these
mimics with Se–N bond have been developed with the assumption
that the enzyme GPx may have a cyclic selenenamide structure in
its oxidized form and the peptidic nitrogen atoms may function
similarly in the formation of cyclic selenenamide species in the
natural enzyme GPx.
Based on these observations, various organoselenium com-
pounds containing heteroatoms, i.e. nitrogen in close proximity to
the selenium has been synthesized in order to study their GPx like
Open access under the Elsevier OA license.activity. Wilson et al. observed that the inclusion of a strongly basic
amino group proximal to the active selenium atom in the molecule
is desirable as it would be expected to catalyze the reaction of
thiols with intermediates like diselenides and selenosulﬁdes. Pre-
sumably, the base functions to provide a source of nucleophilic
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hiolate anion. They also observed that the selenosulﬁde and dise-
enide did not react with thiol under neutral conditions. Upon the
ddition of a strong amine base, however, both gave the seleno-
ate and disulﬁde [2]. Galet et al. worked in the same area and he
roved the importance of the Se–N bond for GPx activity. The 1,3-
enzoselenazolinones,which contain seleniumandnitrogen atoms
n the heterocycle but do not have any direct Se–N bonds were
ested for GPx like activity [3]. All 1,3-benzoselenazolinones were
evoid of GPx activity under a variety of conditions. The work by
ilson et al. to design GPx mimics without direct Se–N bond, also
et with only limited success [2].
To summarize, various organoselenium compounds containing
eteroatoms in close proximity to the selenium have been syn-
hesized in order to study their GPx like activity. In this regard
e have recently reported the synthesis of a new heterocyclic
iselenide with imino residue close to selenium, i.e. 2-((1-(2-
2-(2-(1-(2-hydroxybenzylideneamino) ethyl) phenyl) diselanyl)
henyl) ethylimino) methyl) phenol (Compound A) which showed
romising anti-oxidant potential against Fe (II) induced lipid per-
xidation under different in vitro patho-physiological conditions
4]. However, still there is scarcity of pharmacological and toxico-
ogical data about this comparatively new compound. Thus, to get a
eeper insight about the potential use of Compound A as a possible
harmacological agent, we determined for the ﬁrst time its thiol
eroxidase like activity along with its ability to scavenge free rad-
cals under in vitro conditions. We have also studied whether the
ompound A can inhibit TBARS productions when incubated with
odium nitroprusside (SNP). Similarly the radical scavenging activ-
ty was measured by DPPH and ABTS assays. To take a step ahead
he activity of this compound was further compared with diphenyl
iselenide (DPDS) which we recently showed to posses interesting
iological activities under various pathological situations [4–6].
Organoselenium compounds can interact directly with low
olecular thiols, oxidizing them to disulﬁdes as well [7]. Simi-
arly, reduced cysteinyl residues from proteins can also react with
hese compounds, which may cause, in the case of the enzymes,
he loss of their catalytic activity [8,9]. The mechanism(s) under-
ying either the toxic or protective effect of organochalcogens are
ot completely understood but certainly involves the reaction of
halcogenides with endogenous thiols [10,11]. The facts that (i) the
n vitro test indicating high thiol peroxidase (TPx) or anti-oxidant
ctivity necessarily does not lead to in vivo implications that it will
e a safe compound and (ii) a possible high thiol oxidase (TOx)
ctivity reduces the interest as it may cause oxidation of biological
elevant thiol molecules and enzymes, motivated us to study the
n vivo interaction proﬁle of this compoundwith thiol groups (–SH).
or the purpose we designed an in vivo study, where male adult
istar rats were treated with Compound A to get a better under-
tanding of its toxicological aspects. Along with its interaction with
on-protein thiols (NPSH) we also provided experimental data
bout the interaction of Compound A with -ALA-D and Na+1/K+1
TPase (sulfhydryl containing enzyme). Several other tests have
een performed to get a detail idea about its in vivo behavior which
ould of particular interest in view of its pharmacological and tox-
cological potential.
. Materials and methods
.1. Synthesis of Compound ATo a suspension of (R,S)--methylbenzylamine(10mmol) in
0mL of ether at −78 ◦C was added n-BuLi (2,5M solution in
exane, 10mmol) dropwise. The resulting solution was stirred at
78 ◦C for 30min before TMS (trimethylsilyl chloride) (12mmol)
as added at the same temperature. The reaction mixture wasInteractions 190 (2011) 35–44
allowed to warm to rt naturally and was stirred overnight. To
this solution at 0 ◦C was added n-BuLi (2,5M solution in hex-
ane, 27mmol) drop wise. The reaction mixture was allowed to
slowly warm to room temperature and stirred for 6h. Selenium
(Se) powder (20mmol)was added at 0 ◦C, the reactionmixturewas
allowed to warm to room temperature naturally and was stirred
overnight. NH4Cl saturated solution was added slowly and the
resulting solutionwas oxidized for 2h. After theusualworkupwith
diethyl acetate, the product was isolated by column chromatog-
raphy (EtOAc/MeOH=70:30) as a dark yellow oil in 50% of yield
[12].
2.2. In vitro assays
2.2.1. Thiol peroxidase activity
The catalytic activity of Compound A (Scheme 2) as a GPx model
enzyme, was evaluated according to Tomoda and Iwaoka method
[13] using benzenethiol as a glutathione alternative. The reduc-
tion of H2O2 was monitored through the UV absorption increase
at 305nm, due to diphenyl disulﬁde formation.
2.2.2. Preparation of tissue homogenate and thiobarbituric acid
reactive species (TBARS) assay
Rats were decapitated under mild ether anesthesia and brain,
liver andkidneyswere rapidly removed, placedon ice andweighed.
Tissues were immediately homogenized in cold 10mM Tris–HCl,
pH 7.4 (1/10, w/v) with 10 up-and-down strokes at approximately
1200 rev/min in a Teﬂon-glass homogenizer. The homogenate was
centrifuged for 10min at 4000× g to yield a pellet that was dis-
carded and a low-speed supernatant (S1). An aliquot of 100l of
S1was incubated for 1hat 37 ◦C in thepresenceof bothorganodise-
lenides (ﬁnal concentrations range of 0–100M),with andwithout
the prooxidant, i.e. sodiumnitroprusside (SNP) (ﬁnal concentration
10M). Productions of TBARS were determined as described by
method of Ohkawa et al. [14]. Except that the buffer of color reac-
tion has a pH of 3.4. The color reaction was developed by adding
300l 8.1% SDS to S1, followed by sequential addition of 500l
acetic acid/HCl (pH3.4) and500l 0.8%of thiobarbituric acid (TBA).
This mixture was incubated at 95 ◦C for 1h.
Malondialdehide (MDA), an end product of fatty acid peroxida-
tion, reactswith thiobarbituric acid (TBA) to formacoloredcomplex
which is measured as nmol of MDA/g of tissue at 532nm and the
absorbance was compared to that of a standard curve obtained
using malondialdehyde (MDA).
2.2.3. DPPH radical scavenging assay
The measurement of the (Compound A) scavenging activity
against the radical DPPH• was performed in accordance with Choi
et al. [15]. Brieﬂy, 85M DPPH• was added to a medium containing
different (Compound A) concentrations. The medium was incu-
bated for 30min at room temperature. The decrease in absorbance
measured at 518nm depicted the scavenging activity of the (Com-
pound A) against DPPH•. Ascorbic acid was used as positive control
to determine the maximal decrease in DPPH• absorbance. The val-
ues are expressed in percentage of inhibition of DPPH• absorbance
(% inhibition) in relation to the control values without the (Com-
pound A) (ascorbic acid maximal inhibition was considered 100%
of inhibition).
2.2.4. ABTS radical scavenging assay
The determination of the ABTS radical scavenging effect of Com-
pound A was performed according to the method of Re et al. [16],
with some modiﬁcations. Initially, the ABTS radical was generated
by reacting 7mM ABTS solution in water with 140mM potassium
persulfate in the dark for 12–16h. In the day of the assay, the
ogical Interactions 190 (2011) 35–44 37
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Fig. 1. Thiol peroxidase like activity of DPDS and Compound A (at 10M) in the
presence of hydrogen peroxide. The difference in peroxidase activity was calculatedW. Hassan et al. / Chemico-Biol
re-formed ABTS radical solution was diluted 1:88 (1ml ABTS rad-
cal plus (+) 87ml 10mM potassium phosphate buffer, pH 7.0).
rieﬂy, ABTS radical was added to a medium containing compound
(10–50M). The media were incubated for 30min at 25 ◦C. The
ecrease in absorbance was measured at 734nm, depicting the
cavenging activity of Compound A against ABTS radical. Ascor-
ic acid (10–50M) was used as a positive control to determine
he maximal decrease in ABTS absorbance. Results are expressed
s percentage (%age) of the blank (without compound A).
.3. In vivo assays
.3.1. Animal’s treatment
Rats were divided into four groups, daily weighted and treated
orally) for 3 days (at the interval of 24h) with compound A at 0
canola oil) 10, 25 and50mg/kg. 24h after the last injection animals
ere anesthetized to the collection of blood via heart puncture and
hen killed by decapitation. All the experiments were conducted at
east four times and similar results were obtained.
.3.2. Thiobarbituric acid reactive species (TBARS) levels
TBARS levels, a measure of lipid peroxidation, were determined
s described by Ohkawa et al. [14]. An aliquot of S1 was incubated
ith 0.8% thiobarbituric acid (TBA), acetic acid buffer pH 3.4 and
.1% sodium dodecil sulphate at 95 ◦C for 2h. The color reaction
as measured at 532nm. TBARS levels were expressed as nmol
DA (malondialdehyde)/g of tissue.
.3.3. ı-Aminolevulinate dehydratase (ı-ALA-D) activity
Cerebral, hepatic and renal-ALA-D activity was assayed by the
ethod of Sassa [17] by measuring the rate of product, i.e. por-
hobilinogen (PBG) formation (expressed as nmol PBG/mgptn/h)
xcept that 1M potassium phosphate buffer, pH 6.8 and 12mM
f aminolevulinic acid (ALA) were used. Incubations were carried
ut for 30min at 39 ◦C. The reaction product was determined using
odiﬁed Ehrlich’s reagent at 555nm,with amolar absorption coef-
cient of 6.1×104 M−1 for the Ehrlich–porphobilinogen salt.
.3.4. Na+1/K+1-ATPase activity
Immediately after the sacriﬁce, the kidneys were removed and
he homogenate was prepared in 0.05M Tris–HCl buffer (pH 7.4).
he homogenate was centrifuged at 4000× g at 4 ◦C for 10min
nd supernatant was used for assay of protein Na+1/K+1-ATPase.
he reaction mixture for Na+1/K+1-ATPase activity assay contained
mM MgCl, 125mM NaCl, 20mM KCl and 50mM Tris–HCl, pH 7.4,
n a ﬁnal volume of 500l. The reaction was initiated by addition
f ATP to a ﬁnal concentration of 3.0mM. Controls were carried out
nder the same conditions with the addition of 0.1mM ouabain.
a+1/K+1-ATPase activity was calculated as nmol Pi/mg ptn/min by
he difference between the two assays. Released inorganic phos-
hate (Pi) was measured by the method of Fiske and Subbarow
18].
.3.5. Nonprotein thiols (NPSH) content
Cerebral, hepatic and renal NPSH levels were determined by the
ethodofEllman [19].A sampleof supernatant (500L)wasmixed
1:1) with 10% trichloroacetic acid (500L). After centrifugation,
he protein pellet was discarded and free –SH groups were deter-
ined as nmol/g tissue in a clear supernatant. An aliquot (100L)
f supernatant was added in a 1M potassium phosphate buffer
850L), pH 7.4, and 10mM 5,5′-dithio-bis(2-nitrobenzoic acid)
DTNB) (50L). The color reaction was measured at 412nm.
.3.6. Protein determination
Protein was measured by the method of Bradford [20] using
ovine serum albumin as standard.at different times range from 0s to 300 s at 30 s intervals. Data are the means of
ﬁve to seven independent experiments done in different days. Data are expressed
as mean± SEM.
2.3.7. Ascorbic acid levels
Hepatic and renal ascorbic acid (AA) determination was per-
formed as described by Jacques-Silva et al. [21]. Protein (liver) was
precipitated in 10V of a cold 4% trichloroacetic acid solution. An
aliquot of homogenized sample (300mL), in a ﬁnal volume of 1mL
of the solution, was incubated at 38 ◦C for 3h, then 1mL H2SO4 65%
(v/v) was added to the medium. The reaction product was deter-
mined as g AA/g tissue using color reagent containing 4.5mg/mL
dinitrophenyl hydrazine and CuSO4 (0.075mg/mL).
2.3.8. Hepatic markers of damage
Plasma enzymes, i.e. aspartate aminotransferase (AST) and ala-
nine aminotransferase (ALT)were used as the biochemicalmarkers
for the early acute hepatic damage according to Reitman and
Frankel [22], using a commercial Kit (LABTEST, Diagnostica S.A.,
Minas Gerais, Brazil) and expressed as U/dl.
2.3.9. Renal markers of damage
Renal function was analyzed using a commercial Kit (LABTEST,
Diagnostica S.A., Minas Gerais, Brazil) by determining plasma urea
[23] and creatinine [24] and expressed as mg/dl.Statistical analysis
The results are expressed as the mean± standard error (SEM).
Data were analyzed statistically by analysis of variance (Two-way
ANOVA), followed by univariate analysis and Duncan’s multiple
range test when appropriate.
3. Results
3.1. In vitro
Both compounds, i.e. DPDS and Compound A displayed thiol
peroxidase like (TPx) activity. Two way ANOVA revealed signiﬁ-
cantly (p<0.05) higher (TPx) for Compound A (Fig. 1). Two way
ANOVA of cerebral, renal and hepatic TBARS production indicated
a signiﬁcant main effect of SNP and DPDS/(Compound A) (p<0.05).
It is possible to observe that SNP caused statistically signiﬁcant
increase in TBARS production while both DPDS and Compound A
reduced it in all tested homogenates (Fig. 2). The Compound A also
exhibited strong antioxidant activity in the DPPH and ABTS radical
38 W. Hassan et al. / Chemico-Biological Interactions 190 (2011) 35–44
Fig. 2. Effect of DPDS and Compound A on low-speed supernatant (S1) from brain, kidney and liver against TBARS production. Sodium nitropruside (SNP) at 20M was used
as pro-oxidants to induce TBARS production. TBARS are expressed as nmol of MDA/g of tissue. Data are presented as mean± SEM (n=5). Asterisks represent signiﬁcant effect
as compared with control.
Fig. 3. DPPH• radical scavenging activity of DPDS and Compound A. The values are expressed in percentage of inhibition of DPPH• absorbance (% inhibition) in relation to
the control values without the (Compound A) (ascorbic acid maximal inhibition was considered 100% of inhibition). Data are presented as mean± SEM (n=5) p<0.05 from
respective control. Asterisk represents signiﬁcant effect as compared with control.
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tig. 4. ABTS• radical scavenging activity of DPDS and Compound A. The values are
ata are presented as mean± SEM (n=5) p<0.05 from respective control. Asterisk
cavenging assay for compound A. DPDS did not show any protec-
ion against radical production at none of the tested concentrations
Figs. 3 and 4).
.2. In vivo results
After acute treatment with Compound A, the cerebral, hepatic
nd renal TBARS levelswerenot changed in all treated groupswhen
ompared to control group as shown in (Fig. 5). Two-way ANOVA
evealed that compound A signiﬁcantly increased NPSH concentra-
ion at the highest tested concentration in all tested homogenates
Fig. 6). d-ALA-D (from rats’ brain, liver and kidney) (Fig. 7) and
a+K+ ATPase activitywas not affected by the acute treatmentwith
ompound A at all doses administered (Fig. 8). The levels of ascor-
ic acid were not altered by the treatment with the compound A
n liver and kidney (Fig. 9). AST and ALT plasmatic activities, Urea
nd Creatinine levels were not increased after exposure to differ-
nt doses of CompoundA, indicating that hepatic and renal damage
as not detected (Fig. 10).
. DiscussionBased on observation that the active site of GPx may involve
ome interactions with other amino acid residues that would alter
he enzyme’s activity. Wendel and coworkers [25] reported that
he catalytically active selenocysteine residue in GPx is located at
he N-terminal end of helix a1. It was proposed that the amino acid
Fig. 5. Effect of Compound A on TBARS formation at different dosesssed in percentage of inhibition in relation to control without tested compounds.
ents signiﬁcant effect as compared with control.
residues near the selenium atom might interact weakly with the
selenium, which would certainly stabilize the active site selenolate
and enhance its nucleophilic reactivity. This phenomenon is repli-
cated in our results, which indicates that Compound A has a very
high thiol peroxidase activity than DPDS. We can draw two possi-
ble conclusions as to the effects of an intramolecular imino moiety
in a selenium catalyst: (i) The effects of selenium and the basic
imino nitrogen on the GPx activity are remarkably cooperative for
H2O2 reduction. (ii) The selenium as an active center catalyses the
reduction of H2O2 by interacting with the proximate basic imino
nitrogen.
The basic question in here is why Compound A has better thiol
peroxidase activity thanDPDS?Wecanexplain this issueby assum-
ing a hypothetical cycle (Scheme 1).
The initial step is the reaction of Compound A with phenyl
thiol (PhSH) to produce selenol (SeH)/selenolate (Se−1). This is a
feasible reaction because of hypervalent Se· · ·N interaction which
assist via N–H intermolecular weak hydrogen bonding. This is an
important step in the catalytic cycleof thesemolecules and isdiffer-
ent than normal diselenides because of the unavailability of these
non-bonded interactions, i.e. DPDS. Literature data [26] about sim-
ilar compounds reveals that both theory (MO calculations) and
experiments (77Se-NMR) suggest that the proximate nitrogen base
activates the selenol intermediate into corresponding selenolate
anion, which should play a key role in accelerating the catalytic
cycle [26]. Further oxidation of the Compound A with H2O2 pro-
duces selenenic acid, which then rapidly undergoes bimolecular
. Data are reported as mean± SEM for four rats in each group.
40 W. Hassan et al. / Chemico-Biological Interactions 190 (2011) 35–44
Fig. 6. Effect of Compound A on no-protein thiol concentration at the highest tested concentration. Data are reported as mean± SEM for four rats in each group. Asterisks
represent signiﬁcant effect as compared with control.
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nig. 7. Effect of Compound A on the activity of -ALA-D (expressed as nmol PBG/mg
s mean± SEM for four rats in each group.
isplacement at the selenium atom with two molecules of RSH to
egenerate the initial compound (Scheme 1).
(Scheme 2)
The experimental data of thiol peroxidase indeed reﬂects these
bservations and after comparing it with diphenyl diselenide
ig. 8. Effect of Compound A on renal Na+1/K+1-ATPase. Results are expressed as
mol Pi/mg ptn/min. Data are reported as mean± SEM for four rats in each group.) at different doses. PBG is used as porphobilinogen abbreviation. Data are reported
where there are no Se· · ·N non-bonded interactions shows lower
thiol peroxidase activity (Fig. 1). Our observation also reﬂects the
results obtained by Tomoda and coworker [13]. He studied the
effect of an amino group on the antioxidant activity of GPx by using
variousmodel compounds. The initial reduction rates of H2O2 were
studied by using (PhSH) as a glutathione alternative. The presence
of these amino moieties enhanced thiol peroxidase activities.
The detailed mechanistic studies on similar GPx mimics
revealed the fact that theSe· · ·Nintramolecularnonbonded interac-
tionsmay (i) activate theSe–Sebond towardsanoxidative cleavage,
(ii) stabilise the selenenic acid form of the catalyst against fur-
ther oxidation, (iii) enhance the nucleophilic attack of thiol at
sulfur rather than selenium, and (iv) activate the selenol intermedi-
ate towards oxidation through conversion into its conjugate base,
selenolate. In addition, the amine may serve to deprotonate the
thiol sulfhydryl group and thus provide a high local concentration
of nucleophilic thiolate anion [26].
The synthetic nitrogen-centeredDPPH radical is not biologically
relevant but DPPH• assay is often used to evaluate the ability of
antioxidant to scavenge free radicalswhich are known tobe amajor
factor in biological damages caused by oxidative stress (Fig. 3)
demonstrates DPPH• scavenging activity, expressed in percents,
caused by different concentrations of both compounds.
The results demonstrate that CompoundAhas the ability toneu-
tralize theDPPH• radical orquench free radicals in the formofABTS•
radicals (Fig. 4). Thus, it could prevent or decrease the damage in
a human body caused by free radicals, which, according to Valko
W. Hassan et al. / Chemico-Biological Interactions 190 (2011) 35–44 41
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27] attack biological macromolecules such as lipids, proteins and
NA.
In this study,we demonstrated that SNP, a NOdonor, can induce
ipid peroxidation in vitro, in rat’s tissue homogenates (Fig. 2).
The result presented in Fig. 2 indicated that both Compound A
ndDPDSexerted an antioxidant effect on in vitro SNP induced lipid
eroxidation in rat’s tissue homogenate. A plausible mechanism by
hich these compounds are conferring protective action against
NP induced lipid peroxidation is its thiol peroxidase-like activ-
ty (Fig. 1). However, the compound A showed signiﬁcantly higher
nti-oxidant potential than DPDS which could be attributed to its
igher thiol peroxidase like activity. Another possible explanation
or SNP induced TBARS production could be the direct interac-
Fig. 10. Effect of Compound A on toxicological parameters after 3-doses of acutentration. Data are reported as mean± SEM for four rats in each group.
tion between these compounds with SNP or its derivatives or even
quenching free radicals (shown by effective DPPH (Fig. 3) and
ABTS radical scavenging assays (Fig. 4)) which may have resulted
from lipid peroxidation chain reaction caused by NO released from
SNP.
Data from our laboratory has shown that organochalcogens can
be extremely toxic with a single dose and with a short intervention
[1]. The synthesis of this compound is reported very recently [4]
and since there was no toxicological data (acute) available for this
compound we extend the idea and reported for the 1st time its
acute toxicological data.
Our study focused on in vitro/in vivo and inhibitory effect of
compound A in rat’s tissue preparation. We have evaluated the
e treatment. Data are reported as mean± SEM for four rats in each group.
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nhibitory effect of compound A against SNP mediated lipid per-
xidation at a range of concentrations.
Data concerning compound A distribution in tissues and blood
fter exposure/treatment are lacking in the literature. However,
ata from our laboratory have shown comparative deposition of
iphenyl diselenide, i.e. an organoselenium analogous in liver, kid-
ey, and brain of mice [28]. Although not directly transferable from
ne element to the other, the levels of selenium found in liver after
xposure to acute and chronic relatively high doses of diphenyl
iselenide were found to be close to 100m.
One aspect that deserves to be discussed here is the facts that
ompound A exhibited signiﬁcant in vitro antioxidant activity at
ow micromolar range (5–10M for the case of TBARS inhibition
nd as a mimetic of Gpx). Although it is difﬁcult to predict what
ouldbe theexact in vivodosesneeded toattain these in vitro levels
f compound A, based on previous study [28] with diphenyl dise-
enide (where toxicdoseswereassociatedwith liver concentrations
igher that 100M),wedecidedhere todetermine the in vivoeffect
f compound A using a range of dose that was about 10–50 times
ower than that used for diphenyl diselenide. Our premise was that
he choice of these doses could be associated with non-toxic levels
f compound A in hepatic and cerebral and renal tissues. In fact, the
n vivo results support that the deposition of compound A was not
oxic. However, we cannot ascertain that the levels could be con-
idered similar to that causing antioxidant activity in vitro. Indirect
upport to an antioxidant (and possibly similar concentrations to
Se
N
Se
N
OH
HO
Scheme 2. Molecular structure of compound A.OH
e for Compound A and DPDS.
that needed to inhibit TBARS and to display thiol peroxidase-like
activity) was indicated by an increase in NPSH after treatment with
the highest dose compound A in liver, kidney and brain.
The levels of TBARS, anearliermarker of lipidperoxidation,were
not changed after oral exposure to (compoundA) in rat’s brain, liver
and kidney (Fig. 5). These data suggest that this compound does not
cause any oxidative stress in rat’s tissue after acute treatment.
-Aminolevulinate dehydratase (-ALA-D) is a sulfhydryl con-
taining enzyme that is inhibited by a variety of sulfhydryl
reagents [29–31]. This enzyme catalyses the condensation of two
-aminolevulinic acid (ALA) molecules with the formation of
porphobilinogen, which is a heme precursor [32]. Consequently,
-ALA-D inhibition may impair heme biosynthesis [33] and can
result in the accumulation of ALA, which may affect the aerobic
metabolismandmayhave someprooxidant activity [34]. Data from
our laboratory have shown that -ALA-D activity is signiﬁcantly
inhibited by diphenyl diselenide [1]. In contrast results from this
study indicate that Compound A did not alter the enzyme activity
(Fig. 7) from different organs indicating a fact that in contrast to
diphenyl diselenide -ALA-D it is not an in vivo molecular target
for Compound A.
There are several reports which have demonstrated the impor-
tance of thiol groups for Na+1/K+1-ATPase catalysis. In fact, –SH
groups of this enzyme is highly susceptible to oxidizing agents
[35–37]. Recently DPDS was reported to inhibit the cerebral
Na+1/K+1-ATPase in a concentration dependent manner and that
the inhibition may occur through a change in the crucial thiol
groups of this enzyme [38]. In signiﬁcant contrast to DPDS, com-
pound A at the highest tested concentration did not inhibit the
Na+1/K+1-ATPase activity (Fig. 8).We speculate that the lack of toxi-
city of CompoundA in the ex vivo-ALA-DandNa/KATPase assay is
related to its weak ability to oxidize thiols groups. This observation
was further strengthened by the fact that compound A did not alter
non-protein thiol content in fact it improved NPSH concentration
(Fig. 6).
In order to determine if treatment with Compound A could
cause hepatic damage, we measured plasmatic activities of AST
and ALT. These transaminases are located in different sub-
celullar spaces in hepatocytes, and they are typically released
ogical
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nto the blood after exposure to hepatotoxic chemical agents
39].
Rats exposed to Compound A had markers of hepatic and renal
unction within the normal range (Fig. 10). Corroborating with
hese data, acute exposure to high doses of DPDS did not affect
lasma transaminase activities or levels of urea and creatinine in
odents [40]. Furthermore, previous study has reported that rab-
its chronically exposed to DPDS supplemented diet have levels
f markers of hepatic and renal functions within the normal range
41].
Ascorbic acid is always considered a marker of oxidative stress
nd the reduction of its content may indicate an increase in oxida-
ive stress [21]. Exposure to Compound A did not alter vitamin C
evels in liver and kidney (Fig. 9). Taken together, these data sug-
est that acute exposure to disubstituted diaryl diselenides did not
nduce oxidative stress in rats.
. Conclusion
The in vitro data presented here provides concrete experimen-
al data for the ﬁrst time about this organoselenium compound,
aving high thiol peroxidase activity, strong anti-oxidant poten-
ial against SNP induced lipid peroxidation and radical scavenging
ctivity (more than DPDS). Apart from that we have shown from
ur in vivo data that acute exposure of compound A did not cause
ny enzyme inhibition. The fact that this compound causes low or
egligible toxicity in rats indicates that Compound A is a promis-
ng candidate for future pharmacological studies. The present data
olidiﬁes the position of Compound A as a potential candidate drug
o be tested against a variety of neurodegenerative diseases or free
adical induced damages.
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